Differential expression of micrornas in omental adipose tissue from gestational diabetes mellitus subjects reveals mir-222 as a regulator of erα expression in estrogen-induced insulin resistance

Endocrinology

Volumn 155, Issue 5, 2014, Pages 1982-1990

  Shi, Zhonghua ^a   Zhao, Chun ^a   Guo, Xirong ^a   Ding, Hongjuan ^a   Cui, Yugui ^a   Shen, Rong ^a   Liu, Jiayin ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; GLUCOSE; GLUCOSE TRANSPORTER 4; GLYCOSYLATED HEMOGLOBIN; MICRORNA 222;

3' UNTRANSLATED REGION; ABDOMINAL FAT; ADIPOCYTE; ADULT; ANIMAL CELL; ARTICLE; CELL MATURATION; CELL MEMBRANE; CESAREAN SECTION; CLINICAL ARTICLE; CYTOPLASM; DOWN REGULATION; ESTRADIOL BLOOD LEVEL; FEMALE; GENE OVEREXPRESSION; GENE SILENCING; GLUCOSE TOLERANCE; GLUCOSE TRANSPORT; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LUCIFERASE ASSAY; MOUSE; NONHUMAN; OMENTAL ADIPOSE TISSUE; ORAL GLUCOSE TOLERANCE TEST; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; WILD TYPE;

3T3-L1 CELLS; ADULT; ANIMALS; CESAREAN SECTION; DIABETES, GESTATIONAL; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FEMALE; GENES, REPORTER; GLUCOSE TRANSPORTER TYPE 4; HUMANS; INSULIN; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; MICE; MICRORNAS; MUTANT PROTEINS; PREGNANCY; PROTEIN TRANSPORT; TERM BIRTH; TRANSFECTION; UP-REGULATION; YOUNG ADULT;

EID: 84899460786     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2013-2046     Document Type: Article

References (38)

1. Landon MB, Spong CY, Carpenter MW, et al. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med. 2009;36:1339-1348.
2. Lee AJ, Hiscock RJ, Wein P, Walker SP, Permezel M. Gestational diabetes mellitus: clinical predictors and long-term risk of developing type 2 diabetes: a retrospective cohort study using survival analysis. Diabetes Care. 2007;30:878-883.
3. Dabelea D, Hanson RL, Lindsay RS, et al. Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships. Diabetes. 2000;49:2208-2201.
4. Akbay E, Tiras MB, Yetkin I, et al. Insulin secretion and insulin sensitivity in normal pregnancy and gestational diabetes mellitus. Gynecol Endocrinol. 2003;17:137-142.
5. Fox CS, Massaro JM, Hoffmann U, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation. 2007;116:39-48.
6. Vejrazkova D, Vcelak J, Vankova M, et al. Steroids and insulin resistance in pregnancy. J Steroid BiochemMolBiol. 2014;139:122-129.
7. Nadal A, Alonso-Magdalena P, Soriano S, Ropero AB, Quesada I. The role of oestrogens in the adaptation of islets to insulin resistance. J Physiol. 2009;587:5031-5037.
8. Barros RP, Morani A, Moriscot A, Machado UF. Insulin resistance of pregnancy involves estrogen-induced repression of muscle GLUT4. Mol Cell Endocrinol. 2008;295:24-31.
9. Nadal A, Alonso-Magdalena P, Soriano S, Quesada I, Ropero AB. The pancreatic ß-cell as a target of estrogens and xenoestrogens: Implications for blood glucose homeostasis and diabetes. Mol Cell Endocrinol. 2009;304:63-68.
10. Alonso-Magdalena P, Ropero AB, Carrera MP, et al. A Pancreatic insulin content regulation by the estrogen receptor,ERα. PLoS One. 2008;3:e2069.
11. Ropero AB, Alonso-Magdalena P, Quesada I, Nadal A. The role of estrogen receptors in the control of energy and glucose homeostasis. Steroids. 2008;73:874-879.
12. Jambaldorj B, Terada E, Hosaka T, et al. Cysteine string protein 1 (CSP1) modulates insulin sensitivity by attenuating glucose transporter 4 (GLUT4) vesicle docking with the plasma membrane. JMed Invest. 2013;60:197-204.
13. Im SS, Kwon SK, Kim TH, Kim HI, Ahn YH. Regulation of glucose transporter type 4 isoform gene expression in muscle and adipocytes. IUBMB Life. 2007;59:134-145.
14. Barros RP, Gabbi C, Morani A, Warner M, Gustafsson JA. Participation of ERα and ERß in glucose homeostasis in skeletal muscle and white adipose tissue. Am J Physiol Endocrinol Metab. 2009; 297:E124-E133.
15. Kong YW, Cannell IG, de Moor CH, et al. The mechanism of micro- RNA-mediated translation repression is determined by the promoter of the target gene. Proc Natl Acad Sci USA. 2008;105:8866-8871.
16. Mendell, JT. MicroRNAs: critical regulators of development, cellular physiology and malignancy. Cell Cycle. 2005;4:1179-1184.
17. Zhao C, Dong J, Jiang T, et al. Early second-trimester serummiRNA profiling predicts gestational diabetes mellitus. PLos One. 2011;6: E23925.
18. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2006;29:S43-S48.
19. Zhang CM, Chen XH, Wang B, et al. Over-expression of NYGGF4 inhibits glucose transport in 3T3-L1 adipocytes via attenuated phosphorylation of IRS-1 and Akt. Acta Pharmacol Sin. 2009;30:120-124.
20. Meister G, Landthaler M, Dorsett Y, Tuschl T. Sequence-specific inhibition of microRNA- and siRNA-inducedRNAsilencing.RNA. 2004;10:544-550.
21. Cheruvallath ZS, Kumar RK, Rentel C, Cole DL, Ravikumar VT. Solid phase synthesis of phosphorothioate oligonucleotides utilizing diethyldithiocarbonate disulfide (DDD) as an efficient sulfur transfer reagent. Nucleosides Nucleotides Nucleic Acids. 2003;22:461-468.
22. Zhang CM, Zeng XQ, Zhang R, et al. Effects of NYGGF4 knockdown on insulin sensitivity and mitochondrial function in 3T3-L1 adipocytes. J Bioenerg Biomembr. 2010;42:433-439.
23. Herrera BM, Lockstone HE, Taylor JM, Ria M, Barrett A, Collins S. Global microRNA expression profiles in insulin target tissues in a spontaneous rat model of type 2 diabetes. Diabetologia. 2010;53: 1099-1109.
24. Hossain MM, Schellander K, Tesfaye D, et al. Altered expression of miRNAs in a dihydrotestosterone-induced rat PCOS model. J Ovarian Res. 2013;6:36.
25. Rosenbaum D, Haber RS, Dunaif A. Insulin resistance in polycystic ovary syndrome: decreased expression of GLUT-4 glucose transporters in adipocytes. Am J Physiol. 1993;264:E197-E202.
26. He A, Zhu L, Gupta N, Chang Y, Fang F. Overexpression of micro ribonucleic acid 29, highly up-regulated in diabetic rats, leads to insulin resistance in 3T3-L1 adipocytes. Mol Endocrinol. 2007;21: 2785-2794.
27. Esau C, Kang X, Peralta E, et al.MicroRNA-143regulates adipocyte differentiation. J Biol Chem. 2004;279:52361-52365.
28. Retnakaran R, Qi Y, Connelly PW, Sermer M, Hanley AJ, Zinman B. Low adiponectin concentration during pregnancy predicts postpartum insulin resistance, ß cell dysfunction and fasting glycaemia. Diabetologia. 2010;53:268-276.
29. Livingstone C, Collison M. Sex steroids and insulin resistance. Clin Sci. 2002;103:151-166.
30. Gonzalez C, Alonso A, Fernandez R, Patterson AM. Regulation of insulin receptor substrate-1 in the liver, skeletal muscle and adipose tissue of rats throughout pregnancy. Gynecol Endocrinol. 2003;17: 187-197.
31. Barros R, Gabbi C, Morani A, Warner M, Gustafsson JA. Participation of ERα and ERß in glucose homeostasis in skeletal muscle and white adipose tissue. Am J Physiol Endocrinol Metab. 2009; 297:E124-E133.
32. Barros RP, Machado UF, Warner M, Gustafsson JA. Muscle GLUT4 regulation by estrogen receptors ERß and ERα. Proc Natl Acad Sci USA. 2006;103:1605-1608.
33. Campbell SE, Febbraio MA. Effect of the ovarian hormones on GLUT4 expression and contraction-stimulated glucose uptake. Am J Physiol Endocrinol Metab. 2002;282:E1139-E1146.
34. Gorres BK, Bomhoff GL, Morris JK, Geiger PC. In vivo stimulation of oestrogen receptor α increases insulin-stimulated skeletal muscle glucose uptake. J Physiol. 2011;589:2041-2054.
35. Kim JY, Jo KJ, Kim BJ, Baik HW, Lee SK. 17ß-Estradiol induces an interaction between adenosine monophosphate-activated protein kinase and the insulin signaling pathway in 3T3-L1 adipocytes. Int J Mol Med. 2012;30:979-985.
36. Garrido P, Morán J, Alonso A, González S, González C. 17ß-Estradiol activates glucose uptake via GLUT4 translocation and PI3K/ Akt signaling pathway in MCF-7 cells. Endocrinology. 2013;154: 1979-1989.
37. Rao X, Di Leva G, Li M, et al. MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways. Oncogene. 2011;30:1082-1097.
38. Di Leva G, Gasparini P, Piovan C, et al. MicroRNA cluster 221-222 and estrogen receptor α interactions in breast cancer. J Natl Cancer Inst. 2010;102:706-721.